Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Macugen
Active Ingredient: Pegaptanib sodium 3.47mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Pfizer New Zealand Limited
Manufacturer: Gilead Sciences Inc, San Dimas, California, United States of America
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 16th day of November 2006.
BARRY BORMAN, Acting Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).